Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:663-668
Published online before print August 10, 2009, doi: 10.1161/CIRCULATIONAHA.109.849190
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
120/8/663    most recent
CIRCULATIONAHA.109.849190v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Marijon, E.
Right arrow Articles by Jouven, X.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marijon, E.
Right arrow Articles by Jouven, X.
Related Collections
Right arrow Echocardiography
Right arrow Epidemiology

(Circulation. 2009;120:663-668.)
© 2009 American Heart Association, Inc.


Imaging

Rheumatic Heart Disease Screening by Echocardiography

The Inadequacy of World Health Organization Criteria for Optimizing the Diagnosis of Subclinical Disease

Eloi Marijon, MD; David S. Celermajer, PhD, FRACP; Muriel Tafflet, PhD; Saïd El-Haou, PhD; Dinesh N. Jani, MD; Beatriz Ferreira, MD, PhD; Ana-Olga Mocumbi, MD, PhD; Christophe Paquet, MD, MPH; Daniel Sidi, MD, PhD; Xavier Jouven, MD, PhD

From Université Paris Descartes, AP-HP, Hôpital Européen Georges Pompidou, Paris, France (E.M., X.J.); Paris Cardiovascular Research Center, INSERM 970, Université Paris Descartes, AP-HP, Hôpital Européen Georges Pompidou, Paris, France (E.M., M.T., X.J.); Department of Medicine, Sydney University, Sydney, Australia (D.S.C.); INSERM UMRS-956, Université Pierre et Marie Curie, Paris, France (S.E.H.); Instituto do Coração, Maputo, Mozambique (D.N.J., B.F., A.O.M., D.S.); Institut de Veille Sanitaire, Saint Maurice, France (C.P.); and Université Paris Descartes, AP-HP, Hôpital Necker-Enfants Malades, Paris, France (D.S.).

Correspondence to Eloi Marijon, MD, Hôpital Européen Georges Pompidou, Département de cardiologie, 20 rue Leblanc, 75908 Paris cedex 15, France. E-mail eloi_marijon{at}yahoo.fr

Received January 6, 2009; accepted June 1, 2009.

Background— Early case detection is vital in rheumatic heart disease (RHD) in children to minimize the risk of advanced valvular heart disease by preventive measures. The currently utilized World Health Organization (WHO) criteria for echocardiographic diagnosis of subclinical RHD emphasize the presence of pathological valve regurgitation but do not include valves with morphological features of RHD without pathological regurgitation. We hypothesized that adding morphological features to diagnostic criteria might have significant consequences in terms of case detection rates.

Methods and Results— We screened 2170 randomly selected school children aged 6 to 17 years in Maputo, Mozambique, clinically and by a portable ultrasound system. Two different echocardiographic sets of criteria for RHD were assessed: "WHO" (exclusively Doppler-based) and "combined" (Doppler and morphology-based) criteria. Independent investigators reviewed all suspected RHD cases using a higher-resolution, nonportable ultrasound system. On-site echocardiography identified 18 and 124 children with suspected RHD according to WHO and combined criteria, respectively. After consensus review, 17 were finally considered to have definite RHD according to WHO criteria, and 66 had definite RHD according to combined criteria, giving prevalence rates of 7.8 (95% confidence interval, 4.6 to 12.5) and 30.4 (95% confidence interval, 23.6 to 38.5) per 1000 children, respectively (P<0.0001, exact McNemar test).

Conclusions— Important consideration should be given to echocardiographic criteria for detecting subclinical RHD because the number of cases detected may differ importantly according to the diagnostic criteria utilized. Currently recommended WHO criteria risk missing up to three quarters of cases of subclinically affected and therefore potentially treatable children with RHD.


 

CLINICAL PERSPECTIVE